Obi Greenman
Fortuna: 12 M $ al 30/09/2026
Fortuna: 12 M $ al 30/09/2026
Mr. William M.
Greenman is an Executive Chairman at Cerus Corp.
Mr. Greenman was previously employed as an Independent Director by Aduro BioTech, Inc., an Independent Director by Chinook Therapeutics, Inc., and a Senior Vice President-Biotech Division by Baxter International, Inc. He received his undergraduate degree from Stanford University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERUS CORPORATION 2,51 % | 30/06/2026 | 5.053.036 ( 2,51 % ) | 12 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CERUS CORPORATION | Presidente | 16/03/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 11/08/2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/1995 |
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chinook Therapeutics, Inc.
Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.